Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InfuSystems Holdings, Inc. (INFU : AMEX)

• Company Description    InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management. Number of Employees: 514

• Price / Volume Information    Yesterday's Closing Price: $10.29 Daily Weekly Monthly 20 Day Moving Average: 189,937 shares Shares Outstanding: 20.34 (millions) Market Capitalization: $209.26 (millions) Beta: 1.80 52 Week High: $11.04 52 Week Low: $4.61 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 7.08% 7.31% 12 Week 7.97% 3.93% Year To Date 21.77% 6.58%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3851 West Hamlin Road - Rochester Hills,MI 48309 USA ph: 248-291-1210 fax: 800-455-4338 None http://www.infusystem.com

• General Corporate Information    Officers Richard DiIorio - Chief Executive Officer and Director Scott Shuda - Chairman Carrie Lachance - President and Chief Operating Officer Barry Steele - Chief Financial Officer Kenneth Eichenbaum - Director Peer Information InfuSystems Holdings, Inc. (BJCT) InfuSystems Holdings, Inc. (CADMQ) InfuSystems Holdings, Inc. (APNO) InfuSystems Holdings, Inc. (UPDC) InfuSystems Holdings, Inc. (IMTIQ) InfuSystems Holdings, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 45685K102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/03/26 Share - Related Items Shares Outstanding: 20.34 Most Recent Split Date: (:1) Beta: 1.80 Market Capitalization: $209.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.06 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.28 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/03/26

• Fundamental Ratios P/E Current FY Estimate: 36.10 Trailing 12 Months: 39.58 PEG Ratio: - Price Ratios Price/Book: 3.79 Price/Cash Flow: 14.66 Price / Sales: 1.48 EPS Growth vs. Year Ago Period: 37.50% vs. Previous Quarter: -8.33% Sales Growth vs. Year Ago Period: 3.31% vs. Previous Quarter: 1.35% ROE 09/30/25 - 9.92 06/30/25 - 9.11 03/31/25 - 5.76 ROA 09/30/25 - 5.42 06/30/25 - 4.90 03/31/25 - 3.03 Current Ratio 09/30/25 - 1.90 06/30/25 - 2.19 03/31/25 - 2.21 Quick Ratio 09/30/25 - - 06/30/25 - 1.84 03/31/25 - 1.83 Operating Margin 09/30/25 - 3.92 06/30/25 - 3.63 03/31/25 - 2.32 Net Margin 09/30/25 - 3.92 06/30/25 - 3.63 03/31/25 - 2.32 Pre-Tax Margin 09/30/25 - 6.66 06/30/25 - 6.25 03/31/25 - 4.80 Book Value 09/30/25 - 2.73 06/30/25 - 2.67 03/31/25 - 2.62 Inventory Turnover 09/30/25 - 10.55 06/30/25 - 10.18 03/31/25 - 9.86 Debt-to-Equity 09/30/25 - 0.38 06/30/25 - 0.48 03/31/25 - 0.52 Debt-to-Capital 09/30/25 - 27.40 06/30/25 - 32.58 03/31/25 - 34.23

Powered by Zacks Investment Research ©